| 臺大學術典藏 |
2021-02-05T07:26:14Z |
Clinical outcomes in non-small cell lung cancers harboring different exon 19 deletions in EGFR
|
KUEI-PIN CHUNG; Wu S.-G.; Wu J.-Y.; Yang J.-H.; Yu C.-J.; Wei P.-F.; Shih J.-Y.; Yang P.-C. |
| 臺大學術典藏 |
2021-02-05T07:26:10Z |
Significant clinical factors associated with long-term mortality in critical cancer patients requiring prolonged mechanical ventilation
|
Keng L.-T.;Kuei-Pin Chung;Lin S.-Y.;Liang S.-K.;Cheng J.-C.;Chen I.-C.;Chen Y.-F.;Chang H.-T.;Hsu C.-L.;Jerng J.-S.;Wang H.-C.;Kuo P.-H.;Wu H.-D.;Shih J.-Y.;Yu C.-J.; Keng L.-T.; KUEI-PIN CHUNG; Lin S.-Y.; Liang S.-K.; Cheng J.-C.; Chen I.-C.; Chen Y.-F.; Chang H.-T.; Hsu C.-L.; Jerng J.-S.; Wang H.-C.; Kuo P.-H.; Wu H.-D.; Shih J.-Y.; Yu C.-J. |
| 臺大學術典藏 |
2021-02-05T07:26:09Z |
Multi-kinase framework promotes proliferation and invasion of lung adenocarcinoma through activation of dynamin-related protein 1
|
Kuei-Pin Chung;Huang Y.-L.;Chen Y.-J.;Juan Y.-H.;Hsu C.-L.;Nakahira K.;Huang Y.-T.;Lin M.-W.;Wu S.-G.;Shih J.-Y.;Chang Y.-L.;Yu C.-J.; KUEI-PIN CHUNG; Huang Y.-L.; Chen Y.-J.; Juan Y.-H.; Hsu C.-L.; Nakahira K.; Huang Y.-T.; Lin M.-W.; Wu S.-G.; Shih J.-Y.; Chang Y.-L.; Yu C.-J. |
| 臺大學術典藏 |
2021-01-28T01:06:43Z |
EGFR intron 1 dinucleotide repeat polymorphism is associated with the occurrence of skin rash with gefitinib treatment
|
Huang C.-L.; Yang C.-H.; KUN-HUEI YEH; Hu F.-C.; Chen K.-Y.; Shih J.-Y.; Lin Z.-Z.; Yu C.-J.; Cheng A.-L.; Yang P.-C. |
| 臺大學術典藏 |
2021-01-27T01:38:20Z |
Prognosis of non-small cell lung cancer patients by detecting circulating cancer cells in the peripheral blood with multiple marker genes
|
Sher Y.-P.;Shih J.-Y.;Yang P.-C.;Roffler S.R.;Chu Y.-W.;Wu C.-W.;Chia-Li Yu;Peck K.; Sher Y.-P.; Shih J.-Y.; Yang P.-C.; Roffler S.R.; Chu Y.-W.; Wu C.-W.; CHIA-LI YU; Peck K. |
| 臺大學術典藏 |
2021-01-12T03:00:19Z |
The value of radial endobronchial ultrasound-guided bronchial brushing in peripheral non-squamous non-small cell lung cancer
|
Ho C.-C.; Liao W.-Y.; Lin C.-K.; Hsu C.-L.; Shih J.-Y.; KAI-LUN YU; Tsai T.-H. |
| 臺大學術典藏 |
2021-01-08T03:40:20Z |
Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study
|
Shih J.-Y.; Ko J.-C.; Ho C.-C.; Liao W.-Y.; Lee M.-R.; SHENG-KAI LIANG |
| 臺大學術典藏 |
2021-01-08T03:40:20Z |
Significant clinical factors associated with long-term mortality in critical cancer patients requiring prolonged mechanical ventilation
|
Wang H.-C.; Hsu C.-L.; Jerng J.-S.; Chen Y.-F.; Chang H.-T.; Chen I.-C.; Cheng J.-C.; SHENG-KAI LIANG; Lin S.-Y.; Keng L.-T.; Chung K.-P.; Kuo P.-H.; Wu H.-D.; Shih J.-Y.; Yu C.-J. |
| 臺大學術典藏 |
2021-01-08T03:40:20Z |
Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma
|
Shih J.-Y.; Ko J.-C.; Lee M.-R.; Keng L.-T.; Hsieh M.-S.; SHENG-KAI LIANG |
| 臺大學術典藏 |
2021-01-08T03:40:19Z |
Afatinib is effective in the treatment of lung adenocarcinoma with uncommon EGFR p.L747P and p.L747S mutations
|
SHENG-KAI LIANG; Ko J.-C.; Yang J.C.-H.; Shih J.-Y. |
| 臺大學術典藏 |
2021-01-08T02:56:48Z |
Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma
|
Liang S.-K.;Hsieh M.-S.;Lee M.-R.;Li-Ta Keng;Ko J.-C.;Shih J.-Y.; Liang S.-K.; Hsieh M.-S.; Lee M.-R.; LI-TA KENG; Ko J.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2021-01-08T02:56:46Z |
Significant clinical factors associated with long-term mortality in critical cancer patients requiring prolonged mechanical ventilation
|
Yen-Fu Chen; I-Chun Chen; Jui-Chen Cheng; SHENG-KAI LIANG; Shu-Yung Lin; Li-Ta Keng;Chung K.-P.;Lin S.-Y.;Liang S.-K.;Cheng J.-C.;Chen I.-C.;Chen Y.-F.;Chang H.-T.;Hsu C.-L.;Jerng J.-S.;Wang H.-C.;Kuo P.-H.;Wu H.-D.;Shih J.-Y.;Yu C.-J.; LI-TA KENG; Kuei-Pin Chung; Hou-Tai Chang; Chia-Lin Hsu; Jih-Shuin Jerng; Hao-Chien Wang; Ping-Hung Kuo; Huey-Dong Wu; Jin-Yuan Shih; Chong-Jen Yu |
| 國立成功大學 |
2021 |
Resistance profiles of anaplastic lymphoma kinase tyrosine kinase inhibitors in advanced non–small-cell lung cancer: a multicenter study using targeted next-generation sequencing
|
Lin, Y.-T.;Chiang, Chiang C.-L.;Hung, J.-Y.;Lee, M.-H.;Su, W.-C.;Wu, S.-Y.;Wei, Y.-F.;Lee, K.-Y.;Tseng, Y.-H.;Su, J.;Chung, H.-P.;Lin, C.-B.;Ku, W.-H.;Chiang, T.-S.;Chiu, Chiu C.-H.;Shih, J.-Y. |
| 國立成功大學 |
2021 |
Effects of renal impairment on cardiac remodeling and clinical outcomes after myocardial infarction
|
Chiang, Chiang C.-Y.;Huang, S.-C.;Chen, M.;Shih, J.-Y.;Hong, C.-S.;Wu, N.-C.;Ho, C.-H.;Wu, C.C.;Chen, Z.-C.;Chang, W.-T. |
| 國立成功大學 |
2021 |
The predictive value of global longitudinal strain in patients with heart failure mid-range ejection fraction
|
Chang, W.-T.;Lin, C.H.;Hong, C.-S.;Liao, C.-T.;Liu, Y.-W.;Chen, Z.-C.;Shih, J.-Y. |
| 國立成功大學 |
2021 |
Dapagliflozin improves cardiac hemodynamics and mitigates arrhythmogenesis in mitral regurgitation-induced myocardial dysfunction
|
Lin, Y.-W.;Chen, Chen C.-Y.;Shih, J.-Y.;Cheng, B.-C.;Chang, Chang C.-P.;Lin, M.-T.;Ho, C.-H.;Chen, Z.-C.;Fisch, S.;Chang, W.-T. |
| 臺大學術典藏 |
2020-12-28T12:03:34Z |
In-hospital implementation of evidence-based, medications is associated with improved survival, in diabetic patients with acute coronary, syndrome - Data from TSOC ACS-DM registry
|
Shyu K.-G.; Lin J.-F.; Lei M.-H.; Chiang C.-E.; Chang K.-C.; HWANG, JUEY-JEN; Voon W.-C.; Hsieh I.-C.; Chong J.-T.; Lin W.-S.; Hsu C.-N.; Ueng K.-C.; Hsia C.-P.; Liu J.-C.; Yeh J.-S.; Mar G.-Y.; Shih J.-Y.; Kuo J.-Y.; Tsao H.-M.; Tseng W.-K.; Yang C.-H.; Chang C.-C.; Chen K.-C.; Yin W.-H.; Wu C.-C.; Chan S.-H.; Wu Y.-W.; Wang K.Y. |
| 臺大學術典藏 |
2020-12-28T06:26:53Z |
Cardiac involvement in malignancies: Case 1. Favorable outcome of a patient with cardiac invasion from non-small-cell lung carcinoma
|
Chang Y.-L.; Shih J.-Y.; Ko P.C.-I.; MIN-SHAN TSAI; Min-Shan Tsai;Ko P.C.-I.;Shih J.-Y.;Chang Y.-L.;Chen S.-C.;Chiang W.-C.;Chen W.-J.; Chen S.-C.; Chiang W.-C.; Chen W.-J. |
| 臺大學術典藏 |
2020-12-24T08:26:53Z |
Cardiac involvement in malignancies: Case 1. Favorable outcome of a patient with cardiac invasion from non-small-cell lung carcinoma
|
Chiang W.-C.; Chen S.-C.; Chang Y.-L.; Shih J.-Y.; PATRICK CHOW-IN KO; Tsai M.-S.; Tsai M.-S.;Patrick Chow-In Ko;Shih J.-Y.;Chang Y.-L.;Chen S.-C.;Chiang W.-C.;Chen W.-J.; Chen W.-J. |
| 臺大學術典藏 |
2020-12-24T07:01:25Z |
Estimated creatinine clearance rate is associated with the treatment effectiveness and toxicity of pemetrexed as continuation maintenance therapy for advanced nonsquamous non-small-cell lung cancer
|
Yang P.-C.; Yu C.-J.; Shih J.-Y.; Chen K.-Y.; JENQ-WEN HUANG; Lin J.-W.; Chen C.-Y.; Chen C.-Y.;Lin J.-W.;Jenq-Wen Huang;Chen K.-Y.;Shih J.-Y.;Yu C.-J.;Yang P.-C. |
| 臺大學術典藏 |
2020-12-24T03:18:54Z |
Advanced non-small cell lung cancer in patients aged 45 years or younger: Outcomes and prognostic factors
|
Yang P.-C.; Yang C.-H.; Yu C.-J.; Ho C.-C.; Shih J.-Y.; Chen K.-Y.; CHIA-LIN HSU |
| 臺大學術典藏 |
2020-12-24T03:18:48Z |
Significant clinical factors associated with long-term mortality in critical cancer patients requiring prolonged mechanical ventilation
|
Yu C.-J.; Shih J.-Y.; Wu H.-D.; Kuo P.-H.; Keng L.-T.;Chung K.-P.;Lin S.-Y.;Liang S.-K.;Cheng J.-C.;Chen I.-C.;Chen Y.-F.;Chang H.-T.;Chia-Lin Hsu;Jerng J.-S.;Wang H.-C.;Kuo P.-H.;Wu H.-D.;Shih J.-Y.;Yu C.-J.; Keng L.-T.; Chung K.-P.; Lin S.-Y.; Liang S.-K.; Cheng J.-C.; Chen I.-C.; Chen Y.-F.; Chang H.-T.; CHIA-LIN HSU; Jerng J.-S.; Wang H.-C. |
| 臺大學術典藏 |
2020-12-24T03:18:47Z |
Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations
|
Lin Y.-T.;Chen J.-S.;Liao W.-Y.;Ho C.-C.;Chia-Lin Hsu;Yang C.-Y.;Chen K.-Y.;Lee J.-H.;Lin Z.-Z.;Shih J.-Y.;Yang J.C.-H.;Yu C.-J.; Lin Y.-T.; Chen J.-S.; Liao W.-Y.; Ho C.-C.; CHIA-LIN HSU; Yang C.-Y.; Chen K.-Y.; Lee J.-H.; Lin Z.-Z.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2020-12-24T03:18:47Z |
The value of radial endobronchial ultrasound-guided bronchial brushing in peripheral non-squamous non-small cell lung cancer
|
Yu K.-L.;Tsai T.-H.;Ho C.-C.;Liao W.-Y.;Lin C.-K.;Chia-Lin Hsu;Shih J.-Y.; Yu K.-L.; Tsai T.-H.; Ho C.-C.; Liao W.-Y.; Lin C.-K.; CHIA-LIN HSU; Shih J.-Y. |
| 臺大學術典藏 |
2020-12-24T03:18:46Z |
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
|
Yang C.-Y.;Liao W.-Y.;Ho C.-C.;Chen K.-Y.;Tsai T.-H.;Chia-Lin Hsu;Liu Y.-N.;Su K.-Y.;Chang Y.-L.;Wu C.-T.;Liao B.-C.;Hsu C.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.-H.;Yu C.-J.; Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; CHIA-LIN HSU; Liu Y.-N.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
